Corporate News

• May 9, 2013
  GARDASIL^® Available to Developing Countries through UNICEF Tender

• April 22, 2013
  Merck invests in pan-Canadian life sciences research innovation sector

• Apr. 18, 2013
  Merck renews commitment to the education of tomorrow's scientific innovators

• Dec. 20, 2012
  Merck Invests in Life Science Sector of Québec

• Nov. 26, 2012
  Merck Invests in Montréal's Life Sciences Research Sector

• Nov. 15, 2012
  VICTRELIS™ honoured with the 2012 Prix Galien

• Nov. 12, 2012
  MERCK DONATES HALF A MILLION DOLLARS TO COMBAT MATERNAL MORTALITY IN HAITI

• Nov. 1, 2012
  Merck Canada to Unite its Human Health, Consumer Care and Animal Health Divisions Under One Roof

• Oct. 11, 2012
  On World Sight Day, Merck and Partners Celebrate 25 Years Of Successful Collaboration to Help Eliminated River Blindness

• Sep. 21, 2012
  Merck Canada Working Hands-On to Advance Maternal Health as Part of Community Action Day

• May. 31, 2012
  Merck Applauds This Year's Bourse Fernand-Seguin Recipients

• Apr. 19, 2012
  Merck - An Ongoing Commitment to the Education of Tomorrow's Scientific Innovators

• Mar. 26, 2012
  Merck Lumira Biosciences Fund Launched to Fuel Life Science Innovation in Québec

• Jan. 19, 2012
  Merck Resolves Vioxx^® Litigation in Canada

• Nov. 1, 2011
  Merck Canada to bring state-of-the-art mobile personal health record technology to Canadian doctors

• Oct. 25, 2011
  Merck Canada confirms its Pointe Claire facility as a Centre of Excellence for manufacturing liquids, ointments and creams

• Aug. 3, 2011
  VICTRELIS^™ Approved in Canada: First in new class of drugs to significantly improve
  clearance of chronic hepatitis C virus from the body

• Jun. 29, 2011
  Merck Announces New Name for its Animal Health Division

• May 19, 2011
  Merck Applauds This Year's Bourse Fernand-Seguin Recipients

• May 13, 2011
  Merck Canada Extends Community Action Day across Canada

• Apr. 14, 2011
  Merck Canada - A 20-Year Partnership With The Science Fairs

• Feb. 18, 2011
  Merck Canada Invests $6.8 Million in Research in Quebec

• Jan. 26, 2011
  Merck Canada Invests $5 Million in Quebec Consortium for Drug Discovery to Support
  Biopharmaceutical Research

The information contained in each news release posted on this page was factually accurate
on the date it was issued. The company assumes no duty to update the information to reflect subsequent developments. Readers of the news releases should not rely upon the information
as current or accurate after their issuance dates.